Evidence map›Paper›PMID 34324408›Full record

ArticleHuman vaccines & immunotherapeutics2021

Acceptability of COVID-19 vaccine in the working-age population in Shanghai city: a cross-sectional study.

Linlin Wu, Zhuoying Huang, Xiang Guo, Jiechen Liu, Xiaodong Sun

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Linlin WuDepartmen of Immunization Program, Shanghai Municipal Centers for Disease Prevention and Control, Shanghai, China.
Zhuoying HuangDepartmen of Immunization Program, Shanghai Municipal Centers for Disease Prevention and Control, Shanghai, China.
Xiang GuoDepartmen of Immunization Program, Shanghai Municipal Centers for Disease Prevention and Control, Shanghai, China.
Jiechen LiuDepartmen of Immunization Program, Shanghai Municipal Centers for Disease Prevention and Control, Shanghai, China.
Xiaodong SunDepartmen of Immunization Program, Shanghai Municipal Centers for Disease Prevention and Control, Shanghai, China.
Shanghai Municipal Center For Disease Control Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is still an enormous threat to global health and the economy. Although China has adopted effective measures to control the outbreak, there is still a risk of local transmission from imported cases. Meanwhile, considering the high mortality rate and rapid spread of the disease, a safe and effective vaccine is urgently needed to control the pandemic. With COVID-19 vaccines becoming available to the population, it has become important to know about their acceptance in the population. This is important to enable high vaccination coverage rates and reflects the demand within the general population. An cross-sectional survey was conducted during October 2020 in Shanghai using a well-designed questionnaire, which aimed to evaluate the acceptability of COVID-19 vaccines and to identify the factors affecting its acceptability among working-age adults in Shanghai, China. We found that the acceptability of COVID-19 vaccines was high in work-age adults in Shanghai, China. The factors affecting the acceptability of vaccination identified in this study can provide guides to increase COVID-19 vaccine acceptability in future.

Indexed as

COVID-19COVID-19 VaccinesAdultChinaCross-Sectional StudiesHumansSARS-CoV-2VaccinationCOVID-19 VaccinesacceptabilityChinaCOVID-19SARS-COV-2vaccine

Identifiers

PMID34324408
PMCPMC8828131
OpenAlexW3186457109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.